Ticker
RNXTCompany Name
RENOVORX INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Capital Expenditure | Free Cash Flow | Net Cash Flow - Operations |
---|---|---|---|
6/30/2025 | $ 14K | $ -10.32M | $ -10.31M |
3/31/2025 | $ 14K | $ -10.32M | $ -10.3M |
12/31/2024 | $ 12K | $ -9.14M | $ -9.13M |
9/30/2024 | $ 0 | $ -8.75M | $ -8.75M |
6/30/2024 | $ 0 | $ -9.28M | $ -9.28M |
3/31/2024 | $ 0 | $ -9.76M | $ -9.76M |
12/31/2023 | $ 0 | $ -10.26M | $ -10.26M |
9/30/2023 | $ 0 | $ -9.89M | $ -9.89M |
6/30/2023 | $ 0 | $ -9.83M | $ -9.83M |
3/31/2023 | $ 0 | $ -9.42M | $ -9.42M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations - CapEx
(=) FCF
FCF for RENOVORX INC is calculated as follows: CF - Operations [ $ -3.53M ] - CapEx [ $ 0 ]
(=) FCF [ $ -3.53M ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.3K |
---|---|
min | $ -356.66M |
max | $ 390M |
average | $ 28.88M |
median | $ 565K |
std | $ 118.08M |